Finch Therapeutics Group, Inc. (FNCHQ)

CIK 1733257 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Finch Therapeutics Group, Inc..

Recent SEC filings

FiledFormAccession number
Nov 12, 202415-12G0001193125-24-255195
Nov 4, 2024EFFECT9999999995-24-003352
Nov 1, 2024POS AM0001193125-24-249236
Nov 1, 2024S-8 POS0001193125-24-249234
Nov 1, 2024S-8 POS0001193125-24-249235
Nov 1, 2024S-8 POS0001193125-24-249233
Oct 31, 2024250001193125-24-248169
Oct 21, 20248-K0001193125-24-240034
Aug 13, 202410-Q0000950170-24-096246
Aug 12, 20248-K0001193125-24-198362
Jun 10, 202440000950170-24-071496
May 24, 202440000950170-24-064850
May 24, 20248-K0001193125-24-146454
May 17, 20248-K0001193125-24-141816
May 10, 202410-Q0000950170-24-057912
Apr 26, 202410-K/A0000950170-24-049269
Apr 3, 20248-K0001193125-24-085435
Mar 29, 202440000950170-24-038657
Mar 28, 20241440001958244-24-001152
Mar 25, 202410-K0000950170-24-035952
Feb 23, 20248-K0001193125-24-044511
Dec 13, 2023SC 13G0001014108-23-000151
Nov 27, 202340000950170-23-066155
Nov 22, 20231440001958244-23-002311
Nov 17, 20238-K0001193125-23-279821